FOY-305

· Ono Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FOY-305, covering 2024-04-05 to 2024-04-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19) [Phase 3]